What is Sandostatin® LAR® (octreotide acetate) used for?
SANDOSTATIN LAR is indicated for the treatment of:
Patients with symptoms associated with functional gastro-entero-pancreatic endocrine tumours (e.g. carcinoid tumours with features of the carcinoid syndrome) or patients with advanced neuroendocrine tumours of the midgut or of unknown primary origin where non-midgut sites of origin have been excluded1
Patients with acromegaly in whom surgery is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective1
Patients with TSH-secreting pituitary adenomas:1
when secretion has not normalised after surgery and/or radiotherapy
in patients in whom surgery is inappropriate
in irradiated patients, until radiotherapy is effective.
Resources for you:
Reconstitution and preparation of SANDOSTATIN LAR
Reconstitution and preparation of SANDOSTATIN LAR
Reconstitution and preparation of SANDOSTATIN LAR
A guide on how to prepare and administer SANDOSTATIN LAR.
How to administer and prepare SANDOSTATIN LAR
How to administer and prepare SANDOSTATIN LAR
A step-by-step video on how to prepare and administer SANDOSTATIN LAR.
Resources for your patients:
SASLAR - Home - patient guide - resource card
SASLAR - Home - patient guide - resource card
Your guide to SANDOSTATIN LAR
A guide to help you understand the treatment options you may be offered with SANDOSTATIN LAR.
Sandostatin LAR SmPC
TSH, thyroid-stimulating hormone.
Reference
SANDOSTATIN® LAR® Summary of Product Characteristics.
UK | February 2025 | FA-11214504
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.
Welcome to Pro.Novartis.com
The Novartis portal for UK healthcare professionals (HCPs) and other relevant decision makers* is where you can find promotional information about Novartis products, therapy area materials and professional resources.
*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not health professionals.
This website is designed to be viewed on desktop.
Welcome to Pro.Novartis.com
The Novartis portal for UK healthcare professionals (HCPs) and other relevant decision makers* is where you can find promotional information about Novartis products, therapy area materials and professional resources.
*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not health professionals.
This website is designed to be viewed on desktop.